Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect)
This study is currently recruiting participants.
Verified October 2013
by Bavarian Nordic, Inc.
Study NCT01322490 Information provided by Bavarian Nordic, Inc.
First Received on March 23, 2011. Last Updated on October 23, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer Metastatic
Additional conditions recognized in this trial
Neoplasms, Second Primary
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms by Site
Interventions listed in this trial
Sponsors listed in this trial
Bavarian Nordic, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers